Claim Publisher

European Respiratory Society - ERS

Follow
community rating (0 votes): 

Description

The European Respiratory Society (ERS) is a community of over 35,000 clinicians, scientists, and allied health professionals from over 160 countries. The ERS aims to promote lung health through advocacy initiatives and by advancing the knowledge and understanding of respiratory diseases. The society organizes international congresses, conferences, and educational activities to disseminate the latest research, guidelines, and standards in respiratory medicine. Join the ERS community and access a wide range of resources, training programs, and funding opportunities to support your professional development in the field of respiratory health.

 website

Reviews

No Reviews Yet

Be the first to review one of our webinars!

Upcoming Webinars

Previous Webinars

At the crossroads of obstructive sleep apnoea and dentofacial orthopaedics: exploring research avenues and clinical interventions in childhood
Sleep-disordered breathing and Dento-Facial Orthopaedics, such as Rapid Maxillary Expansion treatment for pediatric OSAS (Obstructive Sleep Apnoea), necessitate histological examinations and clinical investigations, leading to the development of orthopedic therapies and others. This webinar, on the one hand, delves into the intricate relationships between orthodontic interventions and respiratory functions, which are intricately linked with facial development in childhood. The second talk will present an overview of the efficacy of dentofacial and orthodontic treatment on OSAS with a special focus on the morbidity associated with OSAS. Both presentations will also highlight future clinical and research priorities.Chairs: Prof. Dr Karen Spruyt (Paris, France), Prof. Dr Stijn Verhulst (Antwerpen, Belgium)Speakers: Prof. Paola Pirelli (Rome, Italy), Prof. Maria Pia Villa (Rome, Italy)
6/11/2024 3:00 PM
Panel discussion: the importance of getting the dose right in anti-tuberculosis treatment
To successfully treat tuberculosis it is an absolute necessity that the antimicrobial agents used reaches the site of infection in sufficient amounts. This webinar will discuss the link between drug doses and treatment outcome, the main pharmacokinetic processes, site-of-disease pharmacokinetics in pulmonary TB, combination treatment and drug-drug interactions, and the population approach using mathematical models. The target audience includes healthcare professionals, decision makers, policy makers, researchers, and the TB community.
11/23/2023 12:00 PM